Neurology

News of Note

Meet the First H3 Antagonist

Topics: Histamine | Narcolepsy | Neurology | News of Note | Pitolisant | Wakix

On August 15, 2019, pitolisant (Wakix) received FDA approval for narcolepsy, making it the first release of a histamine-3 (H3) antagonist. Unlike other narcolepsy medications, pitolisant is not a controlled substance and lacks abuse potential. Those other options for narcolepsy are the stimulants (methylphenidate and amphetamine), the modafinils, sodiu

Read More